Ignite Creation Date:
2024-05-06 @ 2:52 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04445038
Status:
UNKNOWN
Last Update Posted:
2021-01-28
First Post:
2020-06-21
Brief Title:
Safety Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection
Sponsor:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Organization:
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2021-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-21
First Submit QC Date:
June 21 2020
Study First Post Date:
2020-06-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-25
Last Update Post Date:
2021-01-28
Last Update Post Date Type:
ACTUAL